Dr. Gregory Stock
One of the World's Leading Authorities on Genomics and Biotech
Dr Gregory Stock, a biotech entrepreneur, bioethicist and best-selling author is a leading authority on the broad impacts of genomics and other advanced technologies now reshaping medicine. He Founded Socratic Sciences to produce Fathm, a question-driven communications platform that catalyses understanding, community and social connection at scale as an antidote to traditional social media.
"A pioneer at the intersection of science, ethics and innovation"
Add to my shortlistTopics
- The Biotech Revolution: How it will Transform the Healthcare Sector
- From Darwin to Destiny: Glimpses of the Strange Future Ahead
- Big Data in Healthcare: Best Hope or Worst Fear?
- Courage to Question: Confronting Hard Choices in Business and Life
- The New Economics of Healthcare
- Prosthetics, Designer Babies, and Life Extension: What are the Limits?
- Where are the Wonder Drugs?
Languages
He presents in English.
How he presents
His presentations are provocative, engaging, accessible distillations of recent technological advances and how they will remake our lives and challenge our sense of what it is to be human.
Books & Media
- On the Cusp: New Paths in Healthcare and Medicine
- The Book of Questions
- Redesigning Humans: Our Inevitable Genetic Future
- Engineering the Human Germline
- Metaman: The Merging of Humans and Machines into a Global Superorganism
Microsite
In Detail
Dr. Stock is a strong advocate for aggressive biomedical and healthcare research. He co-founded the Harris Center for Precision Wellness at Icahn School of Medicine at Mt. Sinai, and the Program on Medicine, Technology, and Society at UCLA's School of Medicine. He also co-founded Signum Biosciences, serving as its CEO for 6 years and directed efforts there to develop a promising new therapeutic class for Alzheimer's disease and identify neuroprotective natural products. Co-founded and served for two years as the CEO of Ecoeos, where he helped pioneer the development of ecogenetic tests to gauge personal sensitivity to environmental toxins. Dr Stock serves on the California Advisory Committee on Stem Cells and Reproductive Cloning and is the Associate Director of the Center for Life Science Policy Studies.
WHAT he OFFERS YOU
With a keen focus on the ethical dimensions of scientific progress, Stock explores the intricate balance between technological innovation and moral responsibility, sparking critical reflection and stimulating dialogue on how we can navigate the complex ethical landscapes of the future.